We are live on
!
Find out more
BCM
Beddow Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
18.36%
This Fund
S&P 500
This Quarter
Est. Return
+1.23%
1 Year Est. Return
+18.36%
3 Year Est. Return
+50.71%
5 Year Est. Return
+107.72%
10 Year Est. Return
+272.89%
AUM
$174M
AUM Growth
-$8.44M
(-4.6%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-6.36%
Top 10 Holdings %
Top 10 Hldgs %
45.75%
Holding
50
New
4
Increased
15
Reduced
20
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wabtec
WAB
|
+$3.34M |
| 2 |
AbbVie
ABBV
|
+$1.31M |
| 3 |
Texas Pacific Land
TPL
|
+$856K |
| 4 |
Bladex Inc
BLX
|
+$643K |
| 5 |
Baidu
BIDU
|
+$598K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Metallus
MTUS
|
+$2.33M |
| 2 |
1-800-Flowers.com
FLWS
|
+$1.97M |
| 3 |
Dawson Geophysical
DWSN
|
+$1.53M |
| 4 |
Johnson & Johnson
JNJ
|
+$1.37M |
| 5 |
Philips
PHG
|
+$1.28M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.37% |
| 2 | Consumer Discretionary | 15.71% |
| 3 | Energy | 11.3% |
| 4 | Industrials | 9.56% |
| 5 | Financials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
AbbVie
ABBV
$454B
| $2.37M | 1.37% |
32,642
+16,675
| +104% | +$1.31M |
|
|
27
Baidu
BIDU
$35.8B
| $2.05M | 1.18% |
17,435
+4,200
| +32% | +$598K |
|
28
Bristol-Myers Squibb
BMY
$128B
| $1.74M | 1% |
38,400
-10,660
| -22% | -$497K |
|
29
3M
MMM
$91.9B
| $880K | 0.51% |
6,070
+1,974
| +48% | +$304K |
|
30
Amazon
AMZN
$2.49T
| $517K | 0.3% |
5,460
| – | – |
|
31
Powell Industries
POWL
$7.99B
| $386K | 0.22% |
30,450
| – | – |
|
32
Columbia Sportswear
COLM
$3.25B
| $366K | 0.21% |
3,650
| – | – |
|
|
MNTX
33
DELISTED
Manitex International, Inc.
MNTX
| $254K | 0.15% |
41,500
+500
| +1% | +$3.41K |
|
|
CELG
34
DELISTED
Celgene Corp
CELG
| $252K | 0.15% |
+2,725
| New | +$259K |
|
35
AZZ Inc
AZZ
$4.47B
| $230K | 0.13% |
5,000
| – | – |
|
36
Allstate
ALL
$67.3B
| $229K | 0.13% |
2,250
| – | – |
|
|
NTUS
37
DELISTED
Natus Medical Inc
NTUS
| $214K | 0.12% |
8,338
| – | – |
|
|
ASV
38
DELISTED
ASV Holdings, Inc. Common Stock
ASV
| $178K | 0.1% |
26,032
| – | – |
|
|
39
Metallus
MTUS
$869M
| $163K | 0.09% |
20,100
-257,925
| -93% | -$2.33M |
|
40
Pure Cycle
PCYO
$260M
| $159K | 0.09% |
+15,000
| New | +$150K |
|
|
41
Dawson Geophysical
DWSN
$149M
| $54K | 0.03% |
21,537
-616,996
| -97% | -$1.53M |
|
|
CALA
42
DELISTED
Calithera Biosciences, Inc
CALA
| $44K | 0.03% |
+563
| New | +$63.9K |
|
43
Chevron
CVX
$378B
| – | – |
-2,250
| Closed | -$277K |
|
|
GAP
44
The Gap Inc
GAP
$7.07B
| – | – |
-7,700
| Closed | -$202K |
|
Similar funds
MCP
FCIS
SCM
GFA
RA
OI
GFG
EFA
Beddow Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Beddow Capital Management held 50 positions worth $174M, down 4.6% from $182M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Beddow Capital Management withdrew a net $11M in Q2 2019, closing 3 positions and reducing 20 holdings. Its most notable exit was Chevron, an estimated $277K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Energy.
Against the trend, Beddow Capital Management opened a new position in Celgene Corp worth $252K.
- Beddow Capital Management's largest Q2 2019 buy was Celgene Corp: 2,725 shares worth $252K.
- Beddow Capital Management added most to Wabtec in Q2 2019, an estimated $3.34M increase.
- Beddow Capital Management's biggest Q2 2019 reduction was Metallus, cutting an estimated $2.33M.
- Beddow Capital Management fully exited Chevron in Q2 2019, selling an estimated $277K.
- Beddow Capital Management's ten largest holdings make up 46% of its $174M portfolio in Q2 2019.
- Beddow Capital Management opened 4 new positions and closed 3 in Q2 2019.
- Beddow Capital Management's portfolio value fell 4.6% quarter-over-quarter to $174M.
Based on Beddow Capital Management's 13F filing for Q2 2019, filed 9 Aug 2019.